Cited by

• Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.

  Wellstein A, Palm D, Pitschner HF, Belz GG. Wellstein A, et al. Eur J Clin Pharmacol. 1985;29(2):131-47. doi: 10.1007/BF00547412. Eur J Clin Pharmacol. 1985. PMID: 3000793 Clinical Trial.
• Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.

  Cambridge D, Whiting MV, Allan G. Cambridge D, et al. Br J Pharmacol. 1988 Jan;93(1):165-75. doi: 10.1111/j.1476-5381.1988.tb11418.x. Br J Pharmacol. 1988. PMID: 2894874 Free PMC article.
• Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.

  Brodde OE, Schemuth R, Brinkmann M, Wang XL, Daul A, Borchard U. Brodde OE, et al. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jun;333(2):130-8. doi: 10.1007/BF00506515. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 2875397
• Effect of intracisternal 5,-7-dihydroxytryptamine on the acute antihypertensive action of propranolol in the sino-aortic denervated anaesthetized dog.

  Montastruc JL, Montastruc P. Montastruc JL, et al. Br J Pharmacol. 1981 Mar;72(3):411-7. doi: 10.1111/j.1476-5381.1981.tb10991.x. Br J Pharmacol. 1981. PMID: 7260484 Free PMC article.
• Effects of beta-adrenoceptor antagonist administration on beta 2-adrenoceptor density in human lymphocytes. The role of the "intrinsic sympathomimetic activity".

  Brodde OE, Daul A, Stuka N, O'Hara N, Borchard U. Brodde OE, et al. Naunyn Schmiedebergs Arch Pharmacol. 1985 Feb;328(4):417-22. doi: 10.1007/BF00692910. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 2859531